Singh P - Search Results

1

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. Among authors: singh p. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.

2

Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis.

Ajani JA, Leung L, Singh P, Kurt M, Kim I, Pourrahmat MM, Kanters S. Ajani JA, et al. Among authors: singh p. Eur J Cancer. 2022 Jul;170:119-130. doi: 10.1016/j.ejca.2022.04.027. Epub 2022 May 20. Eur J Cancer. 2022. PMID: 35605522 Free article.

3

Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States.

Haddad R, Cohen EEW, Venkatachalam M, Young K, Singh P, Shaw JW, Korytowsky B, Abraham P, Harrington KJ. Haddad R, et al. Among authors: singh p. J Med Econ. 2020 May;23(5):442-447. doi: 10.1080/13696998.2020.1715414. Epub 2020 Jan 29. J Med Econ. 2020. PMID: 31928375 Free article.

4

Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany.

Singh P, McDonald L, Waldenberger D, Welslau M, von der Heyde E, Gauler T, Dietz A. Singh P, et al. Head Neck. 2021 Nov;43(11):3540-3551. doi: 10.1002/hed.26853. Epub 2021 Sep 6. Head Neck. 2021. PMID: 34487397

5

A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.

Norden AD, Korytowsky B, You M, Kim Le T, Dastani H, Bobiak S, Singh P. Norden AD, et al. Among authors: singh p. J Manag Care Spec Pharm. 2019 Apr;25(4):428-436. doi: 10.18553/jmcp.2019.25.4.428. J Manag Care Spec Pharm. 2019. PMID: 30917077 Free PMC article.

6

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy.

Bonafede MM, Korytowsky B, Singh P, Cai Q, Cappell K, Jariwala-Parikh K, Sill B, Parikh ND. Bonafede MM, et al. Among authors: singh p. J Gastrointest Cancer. 2020 Mar;51(1):217-226. doi: 10.1007/s12029-019-00230-z. J Gastrointest Cancer. 2020. PMID: 31011982 Free PMC article.

7

Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study.

Aly A, Singh P, Korytowsky B, Ling YL, Kale HP, Dastani HB, Botteman MF, Norden AD. Aly A, et al. Among authors: singh p. Neurooncol Pract. 2020 Mar;7(2):164-175. doi: 10.1093/nop/npz042. Epub 2019 Sep 30. Neurooncol Pract. 2020. PMID: 32626585 Free PMC article.

8

Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view.

Xie L, Vo L, Keshishian A, Price K, Singh P, Mardekian J, Bruno A, Baser O, Kim J, Tan W, Trocio J. Xie L, et al. Among authors: singh p. J Med Econ. 2016 Aug;19(8):769-76. doi: 10.3111/13696998.2016.1171774. Epub 2016 Apr 24. J Med Econ. 2016. PMID: 27028360 Free article.

9

Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.

Au TH, Willis C, Reblin M, Peters KB, Nghiemphu PL, Taylor JW, Colman H, Cohen AL, Ormond DR, Chakravarti A, Willmarth N, Menon J, Ma J, Bauer H, Watanabe AH, Ulrich CM, Singh P, Marshall A, Korytowsky B, Stenehjem D, Brixner D. Au TH, et al. Among authors: singh p. Support Care Cancer. 2022 Feb;30(2):1365-1375. doi: 10.1007/s00520-021-06514-0. Epub 2021 Sep 11. Support Care Cancer. 2022. PMID: 34510238 Free PMC article.

10

Real-World Treatment Patterns and Outcomes in Patients with Head and Neck Cancer: Point-in-Time Survey of Oncologists in Italy and Spain.

Singh P, Contente M, Bennett B, Hall J, Bailey H, Bailey A, Zarrelli L, Polanco Sanchez C. Singh P, et al. Adv Ther. 2021 Sep;38(9):4722-4735. doi: 10.1007/s12325-021-01851-2. Epub 2021 Jul 28. Adv Ther. 2021. PMID: 34319551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,246 results

Search Page